Second Malignant Neoplasms After Childhood ALL Therapy (PdL-SMN1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01476462
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : May 24, 2012
Nordic Society for Pediatric Hematology and Oncology
European Organisation for Research and Treatment of Cancer - EORTC
Dana-Farber Cancer Institute
ALL-BFM Study Group
Dutch Childhood Oncology Group
St. Jude Children's Research Hospital
United Kingdom Children's Cancer Study Group
Information provided by (Responsible Party):
Kjeld Schmiegelow, Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2011
  Study Completion Date : December 2011